Abstract
Targeting of MMP-9 could be a useful approach for anticancer therapy. The inhibitory activities of 23 flavonoids on tumor necrosis factors alpha (TNF)-induced matrix metalloproteinases 9 (MMP-9) gene expression were analyzed quantitatively. To elucidate the relationships between the structural properties of flavonoids and their inhibitory activities, comparative molecular field analysis and comparative molecular similarity indices analysis were carried out. The structural conditions required for high inhibitory activity towards TNF-induced MMP-9 gene expression were derived. In addition, for spiraeoside, which showed the best activity among the test compounds, reverse transcription polymerase chain reaction (PCR), real-time PCR analysis, and promoter-reporter assay were performed. Spiraeoside could be a lead compound for the anticancer agents.
Keywords: Matrix metallopeptidase 9, CoMFA, CoMSIA, flavonoid, spiraeoside.
Letters in Drug Design & Discovery
Title:Relationships Between the Structural Properties of Flavonoids and their Inhibitory Activities Against Matrix Metallopeptidase 9
Volume: 14 Issue: 1
Author(s): Soon Young Shin, Hyeryoung Jung, Yearam Jung, Beom Soo Kim, Young Han Lee and Yoongho Lim
Affiliation:
Keywords: Matrix metallopeptidase 9, CoMFA, CoMSIA, flavonoid, spiraeoside.
Abstract: Targeting of MMP-9 could be a useful approach for anticancer therapy. The inhibitory activities of 23 flavonoids on tumor necrosis factors alpha (TNF)-induced matrix metalloproteinases 9 (MMP-9) gene expression were analyzed quantitatively. To elucidate the relationships between the structural properties of flavonoids and their inhibitory activities, comparative molecular field analysis and comparative molecular similarity indices analysis were carried out. The structural conditions required for high inhibitory activity towards TNF-induced MMP-9 gene expression were derived. In addition, for spiraeoside, which showed the best activity among the test compounds, reverse transcription polymerase chain reaction (PCR), real-time PCR analysis, and promoter-reporter assay were performed. Spiraeoside could be a lead compound for the anticancer agents.
Export Options
About this article
Cite this article as:
Shin Young Soon, Jung Hyeryoung, Jung Yearam, Kim Soo Beom, Lee Han Young and Lim Yoongho, Relationships Between the Structural Properties of Flavonoids and their Inhibitory Activities Against Matrix Metallopeptidase 9, Letters in Drug Design & Discovery 2017; 14 (1) . https://dx.doi.org/10.2174/1570180813666160919161434
DOI https://dx.doi.org/10.2174/1570180813666160919161434 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hyperprolactinemia Secondary to Pituitary Microadenoma Versus Haloperidol- A Diagnostic Enigma. A Case Report and Brief Review
Current Drug Safety Overcoming Drug Resistance and Treating Advanced Prostate Cancer
Current Drug Targets Evolution of Novel Non-Steroidal Anti-Inflammatory Drugs with Reduced Gastrointestinal Adverse Effects
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Anticancer Effects of Garlic and Garlic-derived Compounds for Breast Cancer Control
Anti-Cancer Agents in Medicinal Chemistry Blocking the PI3K/PKB Pathway in Tumor Cells
Current Medicinal Chemistry - Anti-Cancer Agents Cytoskeletal Alterations that Confer Resistance to Anti-tubulin Chemotherapeutics
Anti-Cancer Agents in Medicinal Chemistry Mechanisms of Hormonal Regulation of Sertoli Cell Development and Proliferation: A Key Process for Spermatogenesis
Current Molecular Pharmacology Type 1 11 β-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?
Endocrine, Metabolic & Immune Disorders - Drug Targets The Application of Fungal Beta-glucans for the Treatment of Colon Cancer
Anti-Cancer Agents in Medicinal Chemistry Decreased Expression of MYPT1 Contributes to Tumor Angiogenesis and Poor Patient Prognosis in Human Prostate Cancer
Current Molecular Medicine A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
Current Medicinal Chemistry Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Current Drug Targets Effects of PPARγ Ligands on Vascular Tone
Current Molecular Pharmacology NPY Y1 and Y5 Receptor Selective Antagonists as Anti-Obesity Drugs
Current Topics in Medicinal Chemistry Acid Ceramidase, a Double-edged Sword in Cancer Aggression: A Minireview
Current Cancer Drug Targets Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia
Current Pharmaceutical Design Roles of Medicinal Plants and Constituents in Gynecological Cancer Therapy: Current Literature and Future Directions
Current Topics in Medicinal Chemistry Pituitary Dysfunction as a Cause of Cardiovascular Disease
Current Pharmaceutical Design Clinical Pharmacogenetics and Potential Application in Personalized Medicine
Current Drug Metabolism Recent Advances in Biological Strategies for Targeted Drug Delivery
Cardiovascular & Hematological Disorders-Drug Targets